Distribution of data to 51 missions and 106 Korean associations...a joint project with the Hematopoietic Cell Bank Association
OKA (Director Lee Ki-chul) is actively promoting a project to transplant hematopoietic stem cells (造血 細胞, blood-making mother cells) that give hope to overseas Koreans suffering from incurable hematologic tumors.
In the meantime, it has not been easy for patients fighting blood cancer abroad to receive hematopoietic stem cells in their country of residence due to the low probability of human leukocyte antigen (HLA) match between other races.
In response, OKA signed a memorandum of understanding (MOU) with the Korea Hematopoietic Cell Bank Association in December last year so that overseas Koreans who need hematopoietic stem cell transplants can receive transplants smoothly as part of the "Overseas Koreans Care Project."
In addition, OKA recently distributed related promotional materials such as leaflets of the 'Project to Support Overseas Korean Hematopoietic Cell Transplant Patients' to 51 overseas missions and 106 Korean associations.
The promotional materials include a project to recruit donors, a transplant coordination support project to support sample collection along with counseling when transplanting hematopoietic stem cells of overseas Koreans, and a project to support patient treatment costs to support part of the hematopoietic stem cell collection fee of overseas Koreans.
Lee Ki-chul, head of OKA, predicted, "Through this promotion, overseas Koreans who have had difficulty treating hematologic tumors due to the low probability of HLA matches between other races in their country of residence will be able to receive practical help."
https://newsk.net/korea/?idx=19180189&bmode=view
Distribution of data to 51 missions and 106 Korean associations...a joint project with the Hematopoietic Cell Bank Association
OKA (Director Lee Ki-chul) is actively promoting a project to transplant hematopoietic stem cells (造血 細胞, blood-making mother cells) that give hope to overseas Koreans suffering from incurable hematologic tumors.
In the meantime, it has not been easy for patients fighting blood cancer abroad to receive hematopoietic stem cells in their country of residence due to the low probability of human leukocyte antigen (HLA) match between other races.
In response, OKA signed a memorandum of understanding (MOU) with the Korea Hematopoietic Cell Bank Association in December last year so that overseas Koreans who need hematopoietic stem cell transplants can receive transplants smoothly as part of the "Overseas Koreans Care Project."
In addition, OKA recently distributed related promotional materials such as leaflets of the 'Project to Support Overseas Korean Hematopoietic Cell Transplant Patients' to 51 overseas missions and 106 Korean associations.
The promotional materials include a project to recruit donors, a transplant coordination support project to support sample collection along with counseling when transplanting hematopoietic stem cells of overseas Koreans, and a project to support patient treatment costs to support part of the hematopoietic stem cell collection fee of overseas Koreans.
Lee Ki-chul, head of OKA, predicted, "Through this promotion, overseas Koreans who have had difficulty treating hematologic tumors due to the low probability of HLA matches between other races in their country of residence will be able to receive practical help."
https://newsk.net/korea/?idx=19180189&bmode=view